Melius Maintains Buy on Broadcom, $283 Price Target

Analyst: Ben Reitzes 1 min read Reproduced verbatim
Rating
Buy
Unchanged
Target
$283
Outcome
Reached
on July 17, 2025
Melius Research and Broadcom logos

What the analyst said

Melius analyst Ben Reitzes reiterated a Buy rating and $283 price target on Broadcom Limited (NASDAQ: AVGO).

“AVGO is Still One of the “Must-Own” AI Stocks: AVGO benefits from leadership as a fabless semiconductor provider across many categories – but its Networking division (31% of revenues overall) should drive upside with AI accelerators (XPUs) and networking chips largely sold into hyperscaler datacenters.

Broadcom’s engagements for custom XPUs span elite companies like Google, Meta and Bytedance, to the next-generation of AI companies, like OpenAI.

Many of these companies dual source compute from both Nvidia and Broadcom for flexibility around different workloads – but all remain committed to both.

Broadcom can provide multiple chips for each customer, balancing their needs for both high performance and cost- effective performance across a wide range of training and inference workloads.

This capability at hyperscalers uniquely positions Broadcom to capture a large size of the AI compute market long-term.

In addition to the 4 companies mentioned above, we believe that Broadcom has likely added ARM/Softbank, Elon Musk companies, Apple and perhaps even one more hyperscaler to their mix for custom AI accelerators – lending upside to AI semis estimates even after 2027.

We believe Broadcom also boasts one of the stronger senior management teams in our coverage universe with CEO Hock Tan known as an excellent operator and the President of the Semiconductor Group, Charlie Kawwas, aptly leading that division toward the AI promised land.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

AVGO trades at $326. The 21 analysts who set a target in the last 3 months range from $400 to $630, with a median of $515. This $283 target is 45% below the median, the lowest on the Street.

Since the note AVGO has moved +38% (from $236). The 12-month window closed on May 28, 2026.

Track record

This call✓ Target reached on July 17, 2025, 2 months after the note.

Firm track recordMelius Research: 67% of its 9 targets at least a year old were reached within 12 months; on Broadcom, 2 of 2. Accuracy ranking →

Melius Research on Broadcom

Melius Research price targets on Broadcom

2 calls from May 28, 2025 to October 27, 2025. The target went from $283 to $475 (+68%). The rating stayed Buy.

Melius Research targetAVGO share price
  1. October 27, 2025Target raised from $283 (+68%)Buy$475
  2. May 28, 2025 This noteEarliest call shownBuy$283
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.